Etanercept for the Treatment of Chronic Arthritis Related to Chronic Granulomatous Disease: A Case

Pediatric Allergy, Immunology, and Pulmonology
Sibel BalcıMustafa Yılmaz

Abstract

Introduction: Chronic granulomatous disease (CGD) is a rare primary immunodeficiency, in which infections are the main presenting symptoms. Moreover, patients may also experience inflammatory and autoimmune manifestations. With proper management of infections, patients now survive to adulthood, and inflammatory manifestations have become more prominent problems. Treatment of the inflammatory manifestations in CGD is challenging and requires a multidisciplinary approach. Since tumor necrosis factor (TNF)-α has been cited as having a possible role on inflammatory conditions in CGD, etanercept, an anti-TNF agent, may represent a major advance in the management of inflammatory manifestations. Case Presentation: In this report, we described a 15-year-old boy, suffering concurrently both from human leukocyte antigen (HLA)-B27-positive chronic arthritis and CGD, whose arthritis did not respond to treatment with methotrexate and ibuprofen. Remission was achieved 6 months after etanercept initiation and during the next 18 months on medication, we did not encounter any signs of severe infections. Conclusion: Treatment of inflammatory conditions in CGD patients is still challenging in view of the lack of evidence-based therapeutic op...Continue Reading

References

Sep 1, 1975·Proceedings of the National Academy of Sciences of the United States of America·E A CarswellB Williamson
Aug 3, 2004·Pediatrics·Beatriz E MarcianoSteven M Holland
Feb 3, 2006·Pediatrics·Suk See De RavinHarry L Malech
May 16, 2006·Autoimmunity Reviews·Andrea T BorchersM Eric Gershwin
Apr 29, 2008·Arthritis and Rheumatism·Daniel J LovellUNKNOWN Pediatric Rheumatology Collaborative Study Group
May 30, 2008·Seminars in Immunopathology·Michela G SchäppiKarl-Heinz Krause
Oct 1, 2008·The Journal of Allergy and Clinical Immunology·Suk See De RavinHarry L Malech
Aug 29, 2009·Arthritis and Rheumatism·E H GianniniUNKNOWN Pediatric Rheumatology Collaborative Study Group
Nov 10, 2010·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Gulbu UzelSteven M Holland
May 21, 2011·The Journal of Allergy and Clinical Immunology·Christine DeffertMichela G Schäppi
Aug 6, 2013·The Journal of Allergy and Clinical Immunology·Mustafa Yavuz KökerDirk Roos
Jul 6, 2014·The Journal of Allergy and Clinical Immunology·Alessandra MagnaniNizar Mahlaoui
Jul 27, 2014·Journal of Clinical Immunology·Timothy J FranxmanJames R Baker
Aug 30, 2014·Cytokine & Growth Factor Reviews·Lisa M Sedger, Michael F McDermott
Jun 19, 2015·Expert Opinion on Drug Safety·Gerd Horneff
Jul 22, 2015·Iranian Journal of Pediatrics·Taravat SadrosadatMasoud Movahedi
Mar 18, 2016·British Medical Bulletin·Dirk Roos
Jun 15, 2016·Paediatric Drugs·Alessandra Magnani, Nizar Mahlaoui
Feb 2, 2019·Expert Opinion on Drug Safety·Giuseppe MurdacaFrancesco Puppo
Feb 24, 2019·Journal of Autoimmunity·Laura Amaya-UribeM Eric Gershwin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Related Papers

Current Opinion in Hematology
Maria KanariouSofia Tantou
Nihon rinsho. Japanese journal of clinical medicine
K TakikawaM Higami
Ryōikibetsu shōkōgun shirīzu
A Shibata
The Pediatric Infectious Disease Journal
Preeti JaggiBen Z Katz
© 2021 Meta ULC. All rights reserved